Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarafidis

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|March 17, 2016
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesPantelis A Sarafidis, Apostolos Tsapas
Journal of Hypertension|December 14, 2011
A reappraisal of renin-angiotensin system blockade on microalbuminuria development: do they offer anything unique?Pantelis A Sarafidis, George Bakris
Journal of the Cardiometabolic Syndrome|August 8, 2007
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approachPantelis A Sarafidis, George L Bakris
Kidney International|November 19, 2015
Renal dysfunction after endovascular abdominal aortic aneurysm repair: time to use the correct outcome measuresAthanasios N Saratzis, Pantelis A Sarafidis
Journal of the Cardiometabolic Syndrome|November 6, 2008
Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?Pantelis A Sarafidis, Anastasios N Lasaridis
Journal of Hypertension|December 5, 2006
Metabolic effects of beta-blockers: importance of dissociating newer from conventional agentsPantelis A Sarafidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|May 12, 2006
Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?Panteleimon A Sarafidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|April 6, 2006
Are beta blockers passé for the treatment of hypertension?Panteleimon A Sarafidis, George L Bakris
Journal of Hypertension|March 15, 2006
The metabolic syndrome: a glance at its historyPanteleimon A Sarafidis, Peter M Nilsson
Blood Pressure|July 26, 2006
The effects of thiazolidinediones on blood pressure levels - a systematic reviewPantelis A Sarafidis, Peter M Nilsson
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|March 17, 2016
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesPantelis A Sarafidis, Apostolos Tsapas
Journal of Hypertension|December 14, 2011
A reappraisal of renin-angiotensin system blockade on microalbuminuria development: do they offer anything unique?Pantelis A Sarafidis, George Bakris
Journal of the Cardiometabolic Syndrome|August 8, 2007
Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approachPantelis A Sarafidis, George L Bakris
Kidney International|November 19, 2015
Renal dysfunction after endovascular abdominal aortic aneurysm repair: time to use the correct outcome measuresAthanasios N Saratzis, Pantelis A Sarafidis
Journal of the Cardiometabolic Syndrome|November 6, 2008
Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?Pantelis A Sarafidis, Anastasios N Lasaridis
Journal of Hypertension|December 5, 2006
Metabolic effects of beta-blockers: importance of dissociating newer from conventional agentsPantelis A Sarafidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|May 12, 2006
Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?Panteleimon A Sarafidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)|April 6, 2006
Are beta blockers passé for the treatment of hypertension?Panteleimon A Sarafidis, George L Bakris
Journal of Hypertension|March 15, 2006
The metabolic syndrome: a glance at its historyPanteleimon A Sarafidis, Peter M Nilsson
Blood Pressure|July 26, 2006
The effects of thiazolidinediones on blood pressure levels - a systematic reviewPantelis A Sarafidis, Peter M Nilsson
Pageof 21